Market Tracker

04/29 5:16pm ET

Amgen Inc (NASDAQ:AMGN)

158.30
Delayed Data
As of Apr 29
 -2.26 / -1.41%
Today’s Change
130.09
Today|||52-Week Range
181.81
-2.48%
Year-to-Date

Today’s Trading

Previous close160.56
Today’s open159.39
Day’s range156.38 - 161.92
Volume5,386,570
Average volume (3 months)3,709,016
Market cap$118.7B
Dividend yield2.53%
Data as of 3:59pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+35.22%
Earnings growth (this year)+6.75%
Earnings growth (next 5 years)+9.00%
Revenue growth (last year)+6.49%
P/E ratio17.5
Price/Sales5.83
Price/Book4.25

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences-8.79-9.06%
BIIBBiogen-6.09-2.17%
BXLTBaxalta Inc+1.06+2.59%
BAXBaxter International...-0.04-0.09%
Data as of 4:01pm ET, 04/29/2016

Financials

Next reporting dateJuly 26, 2016
EPS forecast (this quarter)$2.74
Annual revenue (last year)$21.3B
Annual profit (last year)$6.9B
Net profit margin32.52%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Madhavan Balachandran
Corporate headquarters
Thousand Oaks, California

Forecasts